In The News Posted July 11, 2019 Share Posted July 11, 2019 ALBUQUERQUE, N.M., July 11, 2019 /PRNewswire/ -- Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract from the National Institutes of Health's National Center for the Advancement of Translational Sciences, for the study of Sickle Cell Disease (SCD). SCD is an... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.